Effects of different kinds of anti-Alzheimer’s disease drugs on cognitive improvement: protocol for a systematic review and network meta-analysis of phase III clinical trials

BACKGROUND: Alzheimer’s disease is a neurodegenerative disease characterized by progressive cognitive decline and dysfunction of independent living ability, with huge economic and healthy burden worldwide. However, there is still a lack of effective long-term drugs to improve cognitive function and...

Descripción completa

Detalles Bibliográficos
Autores principales: Lyu, Diyang, Gong, Min, Zhang, Yong, Lyu, Xuanxin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9063050/
https://www.ncbi.nlm.nih.gov/pubmed/35501927
http://dx.doi.org/10.1186/s13643-022-01964-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9063050/
https://www.ncbi.nlm.nih.gov/pubmed/35501927
http://dx.doi.org/10.1186/s13643-022-01964-x

Ejemplares similares